Pulmonology and Respiratory Care Services for Older Adults
Pulmonology encompasses the diagnosis and management of diseases affecting the lungs, airways, and breathing mechanics — a clinical domain of particular significance for older adults, whose respiratory systems undergo measurable structural decline with age. This page covers the scope of pulmonary services relevant to elderly populations, the functional frameworks governing care delivery, the conditions most commonly encountered, and the clinical and regulatory boundaries that define appropriate specialist involvement. Understanding these boundaries matters because respiratory disease ranks among the leading causes of hospitalization and mortality in adults aged 65 and older in the United States (Centers for Disease Control and Prevention, National Center for Health Statistics).
Definition and scope
Pulmonology is the medical subspecialty focused on the respiratory tract, encompassing the trachea, bronchi, bronchioles, alveoli, pleura, and the thoracic musculature involved in ventilation. Practitioners board-certified in pulmonary disease in the United States complete fellowship training following internal medicine residency, with certification through the American Board of Internal Medicine (ABIM) under its subspecialty framework (ABIM).
For older adults, pulmonology intersects substantially with geriatric medicine specialists and chronic disease management, because aging introduces compounding variables that alter both disease presentation and treatment thresholds. Age-related changes include:
- Decreased chest wall compliance due to thoracic cage stiffening
- Reduced respiratory muscle strength (diaphragm and intercostals)
- Increased residual volume and decreased forced vital capacity (FVC)
- Blunted hypoxic and hypercapnic ventilatory responses
- Impaired mucociliary clearance, increasing infection susceptibility
- Progressive decline in FEV₁ (forced expiratory volume in one second) at approximately 30 mL per year after age 35 (National Heart, Lung, and Blood Institute, NHLBI)
These physiological shifts mean that spirometric reference ranges derived from younger cohorts may not apply directly to elderly patients. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) framework explicitly addresses age-adjusted spirometric interpretation in its annual COPD guidelines (GOLD).
Pulmonary services span outpatient clinics, inpatient consultations, pulmonary function laboratories, bronchoscopy suites, and sleep disorder centers. Sleep-disordered breathing, which overlaps with elder sleep disorder services, is a recognized pulmonary subspecialty domain.
How it works
A standard pulmonary evaluation for an older adult follows a structured diagnostic pathway:
- Clinical history — including dyspnea characterization, cough chronicity, occupational and environmental exposure history, and smoking pack-year quantification
- Physical examination — auscultation, assessment of accessory muscle use, peripheral oxygen saturation measurement
- Spirometry — measurement of FVC, FEV₁, and the FEV₁/FVC ratio; post-bronchodilator testing distinguishes fixed from reversible obstruction
- Imaging — chest radiograph as baseline; high-resolution computed tomography (HRCT) for interstitial, nodular, or pleural disease evaluation
- Additional functional testing — diffusing capacity of the lung for carbon monoxide (DLCO) to assess gas exchange; six-minute walk testing for functional capacity
- Invasive procedures — bronchoscopy with or without bronchoalveolar lavage (BAL) or transbronchial biopsy when histological diagnosis is required
Respiratory care services — distinct from physician pulmonology — are delivered by registered respiratory therapists (RRTs) credentialed through the National Board for Respiratory Care (NBRC) (NBRC). RRTs administer inhaled therapies, manage mechanical ventilation, conduct pulmonary rehabilitation, and operate under physician-authored care plans.
Medicare coverage for pulmonary services is governed by the Centers for Medicare & Medicaid Services (CMS) under Part B for outpatient physician services and diagnostic testing, and under Part A for inpatient respiratory care. Pulmonary rehabilitation is a separately covered benefit under CMS for qualifying diagnoses, subject to documented moderate-to-severe COPD defined by GOLD staging (CMS, Medicare Benefit Policy Manual, Chapter 15).
Common scenarios
The most frequently encountered respiratory conditions in older adult populations include:
Chronic Obstructive Pulmonary Disease (COPD) — characterized by persistent airflow limitation, classified by GOLD into four stages (GOLD 1–4) based on post-bronchodilator FEV₁ as a percentage of predicted value. COPD is the third leading cause of death in the United States (CDC, National Vital Statistics Reports).
Asthma in older adults — distinct from late-onset COPD; often underdiagnosed because dyspnea is misattributed to deconditioning or cardiac disease. The National Asthma Education and Prevention Program (NAEPP), coordinated by NHLBI, provides classification criteria separating intermittent from persistent asthma.
Interstitial Lung Disease (ILD) — a heterogeneous category including idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis, and connective tissue disease-associated ILD. IPF incidence increases with age, with median diagnosis occurring in the mid-60s.
Obstructive Sleep Apnea (OSA) — managed jointly across pulmonology and sleep medicine, with CPAP therapy as the primary intervention. Adherence tracking under CMS requires documented objective data from CPAP device downloads at 31 and 91 days post-initiation.
Lung cancer screening — low-dose CT (LDCT) screening is recommended by the United States Preventive Services Task Force (USPSTF) for adults aged 50 to 80 with a 20 pack-year smoking history who currently smoke or quit within the past 15 years (USPSTF), a threshold updated from prior criteria in 2021.
Pulmonary presentations frequently co-occur with elder cardiology services needs, because heart failure and COPD share overlapping symptom profiles and require coordinated diagnostic differentiation.
Decision boundaries
Referral to a pulmonologist is clinically indicated when primary care evaluation cannot adequately characterize or manage a respiratory condition. Defined triggers include:
- FEV₁/FVC ratio below 0.70 post-bronchodilator with symptoms disproportionate to spirometric severity
- Hemoptysis without an identified source
- Unexplained hypoxemia (SpO₂ below 88% at rest) requiring supplemental oxygen evaluation
- ILD suspected on imaging
- Recurrent pneumonia suggesting structural or immunological etiology
- Lung nodule management per Fleischner Society guidelines (Fleischner Society)
Respiratory care services — as distinct from physician management — are scoped by state licensure boards and by CMS Conditions of Participation (42 CFR Part 482) governing hospital respiratory care departments. Durable medical equipment including home oxygen concentrators, nebulizers, and CPAP devices falls under elder medical equipment and durable goods frameworks, separately from clinical pulmonary management.
Pulmonary rehabilitation occupies a defined boundary: it is a supervised, multidisciplinary program rather than a general exercise prescription. CMS requires 36 individualized sessions per cardiac/pulmonary rehabilitation episode. Referral appropriateness is governed by documented GOLD Stage II or worse COPD or equivalent functional impairment.
End-of-life respiratory planning — including mechanical ventilation preferences, tracheostomy decisions, and oxygen continuation under comfort-focused goals — involves the intersection of pulmonology with hospice and palliative care and elder advance care planning, which address documented directive frameworks separately.
References
- Centers for Disease Control and Prevention, National Center for Health Statistics (NCHS)
- National Heart, Lung, and Blood Institute (NHLBI)
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)
- American Board of Internal Medicine (ABIM) — Pulmonary Disease Certification
- National Board for Respiratory Care (NBRC)
- Centers for Medicare & Medicaid Services — Medicare Benefit Policy Manual, Chapter 15
- U.S. Preventive Services Task Force — Lung Cancer Screening Recommendation (2021)
- Fleischner Society — Pulmonary Nodule Guidelines
- Code of Federal Regulations, 42 CFR Part 482 — Conditions of Participation for Hospitals